Skip to main content
Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden flag Sweden · Delayed Price · Currency is SEK
17.14
-0.32 (-1.83%)
At close: Mar 6, 2026

Cinclus Pharma Holding AB Revenue

In the year 2025, Cinclus Pharma Holding AB had annual revenue of 57.47M SEK with 1,154.80% growth. Cinclus Pharma Holding AB had revenue of 13.63M in the quarter ending December 31, 2025, with 197.64% growth.

Revenue
57.47M
Revenue Growth
+1,154.80%
P/S Ratio
13.57
Revenue / Employee
2.74M
Employees
21
Market Cap
779.97M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202557.47M52.89M1,154.80%
Dec 31, 20244.58M-1.38M-23.14%
Dec 31, 20235.96M-4.61M-43.63%
Dec 31, 202210.57M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Orexo AB 26.00M
Nanexa AB 55.94M
Dicot Pharma AB 200.00K
Enzymatica AB 53.90M
Moberg Pharma AB 13.54M
EQL Pharma AB 425.75M
Cereno Scientific AB 44.27M
Klaria Pharma Holding AB (publ.) 8.99M
Revenue Rankings